Year None20232022202120202019201820172016 Date Latest Press Release October 24, 2022 Eiger BioPharmaceuticals to Host Conference Call for Third Quarter 2022 Financial Results and Business Update on Thursday, November 3 October 11, 2022 Eiger BioPharmaceuticals to Present at the H.C. Wainwright Third Annual Hepatitis B Virus (HBV) Virtual Conference October 5, 2022 Eiger BioPharmaceuticals Provides Update on Plans for Emergency Use Authorization Application Following FDA Feedback September 22, 2022 Eiger BioPharmaceuticals to Present at the 2022 Ladenburg Thalmann Healthcare Conference September 6, 2022 Eiger BioPharmaceuticals Provides Update on Status of Planned Peginterferon Lambda COVID-19 Emergency Use Authorization Application September 1, 2022 Eiger BioPharmaceuticals to Participate in Three Upcoming Investor Conferences August 4, 2022 Eiger BioPharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update July 28, 2022 Eiger BioPharmaceuticals to Host Conference Call for Second Quarter 2022 Financial Results and Business Update on Thursday, August 4 July 20, 2022 Eiger Receives European Approval for Zokinvy® (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies July 18, 2022 Eiger Appoints Senior Human Resources and Organizational Executive Lisa Kelly-Croswell to Board of Directors Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
